Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,356.00
Bid: 12,390.00
Ask: 12,394.00
Change: 28.00 (0.23%)
Spread: 4.00 (0.032%)
Open: 12,364.00
High: 12,454.00
Low: 12,322.00
Prev. Close: 12,328.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK stocks recover on Brexit progress hopes after virus-led pullback

Tue, 22nd Dec 2020 10:10

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Britain's fishing rights offer raises hopes for a deal

* UK economy recovers 16% in Q3, recession risks loom

* AstraZeneca down as asthma drug trial fails

* FTSE 100 up 0.6%, FTSE 250 adds 1.3%
(Updates to market close)

By Medha Singh

Dec 22 (Reuters) - UK stocks bounced on Tuesday as fresh
hopes of a trade deal with the European Union outweighed fears
over a mutated variant of the novel coronavirus that has shut
most of the island country.

The mid-cap FTSE 250, considered a barometer for
Brexit sentiment, added 1.3% as the EU chief negotiator said
both sides were inching towards an agreement on fishing though
the politically sensitive matter remains unresolved.

Banks and industrials and consumer discretionary were the
biggest boost to the domestically focused index.

The blue-chip FTSE 100 closed 0.6% after wiping off
more than half of its gains for December on Monday as UK imposed
tough restrictions and countries around the world shut their
borders to Britain due to worries about the new variant.

"The COVID crisis and Brexit uncertainty look set to hang
over equities for the rest of the calendar year and January
could be a difficult period unless there is progress in getting
the virus under control and clarity on when more people will get
vaccinated," said Russ Mould, investment director at AJ Bell.

Official data showed Britain's economic recovery from its
coronavirus crash was quicker than previously thought in the
third quarter, but new lockdowns are threatening to cause a
another recession.

Drugmaker AstraZeneca Plc slipped 1.5% after its
experimental asthma drug with Amgen Inc failed to meet
the main goal of reducing patients' dependence on steroids in a
late-stage trial.

Irish gas station operator Applegreen Plc rose
2.5% after agreeing to be acquired by a consortium led by B&J
Holdings and Blackstone Infrastructure Partners in a deal that
valued it at around $877.66 million.
(Reporting by Medha Singh and Shivani Kumaresan in Bengaluru;
Editing by Rashmi Aich, Sriraj Kalluvila and Richard Chang)

More News
28 Jun 2023 10:55

The high growth companies that could re-rate in a recession

STOXX 600 up 0.6%, techs among big gainers

*

Read more
27 Jun 2023 08:19

AstraZeneca's diabetes combination treatment approved in China

(Alliance News) - AstraZeneca PLC on Tuesday said its Xigduo XR combination treatment has received approval in China for type-2 diabetes.

Read more
26 Jun 2023 08:39

EU committee recommends expanded approval for AstraZeneca's Soliris

(Alliance News) - AstraZeneca PLC on Monday said Soliris has been recommended for marketing authorisation in the EU for expanded use in generalised myasthenia gravis, gMG.

Read more
22 Jun 2023 14:02

Novo Nordisk says EMA raised safety signal on drugs including semaglutide

Signal included drugs from Eli Lilly, AstraZeneca, Sanofi

*

Read more
22 Jun 2023 08:54

Novo Nordisk shares slip on EMA drug safety signal

COPENHAGEN, June 22 (Reuters) - Novo Nordisk said on Thursday the European Union's drug watchdog had last month raised a thyroid cancer safety signal for several of its drugs including semaglutide, the active ingredient in its popular diabetes and obesity drugs, Ozempic and Wegovy.

Read more
20 Jun 2023 08:33

Lab crunch: British science has nowhere to go

OXFORD, England, June 20 (Reuters) - For Ros Deegan, the thrill of raising $100 million to expand a biotech firm among the dreaming spires of Oxford was soon tempered: unable to find a bigger laboratory, she routinely had to work at home.

Read more
19 Jun 2023 17:09

London stocks lag as miners slip; AstraZeneca weighs

AstraZeneca down on report of China business spin off plan

*

Read more
19 Jun 2023 11:56

Adding equities on disinflation, short squeeze risk - TS Lombard

STOXX 600 down 0.6%

*

Read more
19 Jun 2023 10:50

China spin-off may allow AstraZeneca to avoid "regulatory clampdown"

(Alliance News) - The Financial Times reported on Monday that AstraZeneca PLC has drafted plans to separate its China business amid geopolitical tensions.

Read more
19 Jun 2023 10:48

More to come as bear capitulation drives recent risk rally

STOXX 600 down 0.5%

*

Read more
19 Jun 2023 09:28

AstraZeneca planning spinoff of China business - report

(Sharecast News) - AstraZeneca has reportedly drawn up plans to break out its China business and list it separately in Hong Kong as a way to shelter the company against mounting geopolitical tensions.

Read more
19 Jun 2023 09:13

Cautious start for Europe

STOXX 600 down 0.6%

*

Read more
19 Jun 2023 09:09

LONDON MARKET OPEN: Stocks falter amid weaker outlook for China

(Alliance News) - Stock prices in London opened lower on Monday, ahead of more interest rate decisions, and amid fears for China's slowing economic recovery.

Read more
19 Jun 2023 07:53

LONDON BRIEFING: Severn Trent deal sized up by CMA; Coca-Cola HBC buys

(Alliance News) - Stocks in London are called lower on Monday, ahead of more central bank decisions, while a meeting between US Secretary of State Antony Blinken and his Chinese counterpart put relations between the two nations back under the spotlight.

Read more
19 Jun 2023 07:00

PRESS: AstraZeneca drafts plan to spin-off in China - FT

(Alliance News) - AstraZeneca PLC has drafted plans to separate its China business amid geopolitical tensions, the Financial Times reported on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.